The deal gives the company milestone payments and royalties to a medicine that Sanofi licensed from biotech ImmuNext and expects to be a future blockbuster.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,